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Abstract Formation of blood vessel networks by sprouting angiogenesis is critical for tissue
growth, homeostasis and regeneration. How endothelial cells arise in adequate numbers and
arrange suitably to shape functional vascular networks is poorly understood. Here we show that
YAP/TAZ promote stretch-induced proliferation and rearrangements of endothelial cells whilst
preventing bleeding in developing vessels. Mechanistically, YAP/TAZ increase the turnover of VE-
Cadherin and the formation of junction associated intermediate lamellipodia, promoting both cell
migration and barrier function maintenance. This is achieved in part by lowering BMP signalling.
Consequently, the loss of YAP/TAZ in the mouse leads to stunted sprouting with local aggregation
as well as scarcity of endothelial cells, branching irregularities and junction defects. Forced nuclear
activity of TAZ instead drives hypersprouting and vascular hyperplasia. We propose a new model in
which YAP/TAZ integrate mechanical signals with BMP signaling to maintain junctional compliance
and integrity whilst balancing endothelial cell rearrangements in angiogenic vessels.
DOI: https://doi.org/10.7554/eLife.31037.001
Introduction
A long-standing question in developmental and cell biology relates to how cells integrate mechani-
cal and chemical signals to orchestrate the morphogenic behaviours that ensure adequate tissue pat-
terning. During sprouting angiogenesis, the arrangement and distribution of cells rather than their
numbers appear to drive morphogenesis of the vascular tree. Recent data showing unaltered remod-
elling in the absence of endothelial cell apoptosis and normal branching frequency across a range of
endothelial cell densities support this idea (Watson et al., 2016). In the extreme, however, too few
cells will jeopardize network formation and stability (Phng et al., 2009), whereas too many cells
might compromise vessel calibre control (Watson et al., 2016). Functional network formation there-
fore needs to establish the right number of cells in the right place, and distribute them such that the
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hierarchical branching pattern is supported. What establishes such a balance has remained unclear.
Here we provide evidence for the yes-associated protein 1 (YAP) and its paralog WW domain con-
taining transcription regulator 1 (TAZ) as critical endothelial cell autonomous regulators in this
process.
YAP and TAZ, two transcriptional co-activators initially discovered as effectors of the Hippo sig-
nalling pathway, play a central role in organ size control via regulation of proliferation and apoptosis
(Piccolo et al., 2014; Meng et al., 2016; Yu et al., 2015). In confluent cells, YAP and TAZ are phos-
phorylated by kinases of the Hippo pathway, which induces their retention in the cytoplasm. In
sparse cells, YAP and TAZ can translocate to the nucleus, where they interact with transcription fac-
tors to regulate the expression of pro-proliferative and anti-apoptotic genes. Other stimuli have
been found to regulate YAP and TAZ nuclear translocation and activity – these include, among
others, G-protein coupled receptors (GPCRs) (Yu et al., 2012), junctional proteins
(Giampietro et al., 2015; Schlegelmilch et al., 2011), and mechanical stimuli (Dupont et al., 2011;
Aragona et al., 2013). Furthermore, besides cell proliferation and apoptosis, YAP and TAZ also reg-
ulate cell differentiation (Yu and Guan, 2013), migration (Zhang et al., 2015) and actomyosin con-
traction (Lin et al., 2017). In vascular development, the roles of YAP and TAZ are not fully
understood. Yap null mutant zebrafish develop an initially normal vasculature but display increased
vessel collapse and regression. Yap/Taz double mutant zebrafish die before the onset of circulation
with severe developmental defects, precluding analysis of vascular development in this context
(Nakajima et al., 2017). Endothelial-specific deletion of Yap in mice using the Tie2-Cre transgenic
line is embryonically lethal due to heart valve defects caused by failed endothelial-to-mesenchymal
transition (Zhang et al., 2014). During post-natal development of the mouse retina, YAP was shown
to regulate vascular branching and density by promoting the transcription of Angiopoetin-2 (16).
While these studies point towards an important role for YAP in regulating blood vessel formation
and maintenance, the cellular principles and effectors of YAP/TAZ in endothelial cells in vivo, as well
as the possible interplay between YAP/TAZ and the major signalling pathways regulating angiogene-
sis remain poorly understood.
Here, we used loss and gain of function endothelial specific mouse models to address the roles of
YAP and TAZ in the vasculature. We show that YAP and TAZ are both expressed and active in
sprouting ECs and critical for sprouting angiogenesis. The inducible, endothelial-specific deletion of
YAP and TAZ leads to severe morphogenic defects consistent with impaired junctional remodelling
in vivo. We found that the loss of YAP and TAZ decreased VE-Cadherin turnover and decreased the
frequency of junction associated intermediate lamellipodia. Furthermore, the loss of YAP and TAZ
decreased cell migration and increased cell-cell coupling. We also discovered that endothelial YAP
and TAZ strongly inhibit BMP signalling in vitro and in vivo, and that this is mechanistically linked to
the migration and permeability defects. Together our results suggest that YAP and TAZ integrate
mechanical stimuli with key transcriptional regulators of endothelial sprouting and cell rearrange-
ments during angiogenesis.
Results
YAP and TAZ have distinct expression patterns in endothelial cells of
developing vessels and localise to the nucleus at the sprouting front
Immunofluorescence staining in the postnatal mouse retina showed that YAP and TAZ are distinctly
expressed in the ECs of the developing vasculature (Figure 1). While YAP is evenly expressed
throughout the vasculature (Figure 1A–D), the expression of TAZ is especially prominent at the
sprouting front (Figure 1E–H). Furthermore, YAP is exclusively cytoplasmic in all areas of the retinal
vasculature, with the exception of the sprouting front where some ECs express nuclear YAP,
although at lower levels than in the cytoplasm (Figure 1A’–D’). TAZ staining signal is very low in the
remodelling plexus, arteries and veins (Figure 1E’–H’); at the sprouting front, TAZ is strongly nuclear
in numerous ECs (Figure 1E, green arrowheads and E’), and both nuclear and cytoplasmic in others
(Figure 1E, red arrowheads). The nuclear signal of YAP and TAZ did not correlate with a tip or stalk
cell phenotype; nuclear YAP and TAZ are rather present in a subset of tip and stalk ECs at the
sprouting front. YAP and TAZ were also found at endothelial adherens junctions in veins and in the
remodelling plexus, (yellow arrowheads in Figure 1D’ and F’), as revealed by co-staining for VE-
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Figure 1. YAP and TAZ are expressed throughout the vasculature of developing mouse retinas, and localise to the
nucleus of sprouting endothelial cells. Immunofluorescence staining of YAP (green, A–D and A’–D’) and TAZ
(green, E–H and E’–H’) was performed in wild-type mouse retinas at post-natal day 6 (P6). Retinas were co-stained
with the endothelial membrane marker Isolectin-B4 (IB4; blue) and with antibodies against the endothelial nuclei
Figure 1 continued on next page
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Cadherin (Figure 1—figure supplement 1). Together, these observations suggest that YAP/TAZ are
abundant proteins in the endothelium, which are dynamically regulated during the angiogenic
process.
YAP/TAZ are required for vascular growth, branching and regularity of
the network
To examine the cell-autonomous role of endothelial YAP and TAZ during angiogenesis we crossed
mice bearing floxed alleles of Yap or Taz (Gruber et al., 2016) with mice expressing a tamoxifen-
inducible Cre recombinase driven by the endothelial-restricted Pdgfb promoter (Pdgfb-iCreERT2)
(Claxton et al., 2008). Injection of the offspring with tamoxifen induced loss of YAP and TAZ protein
in ECs during post-natal vascular development, as evidenced by immunofluorescence staining (Fig-
ure 2—figure supplement 1).
Endothelial deletion of YAP or TAZ led to mild vascular defects (Figure 2A,B,C,D). Yapfl/fl Pdgfb-
iCreERT2 mice (Yap iEC-KO) presented reduced radial expansion of the vasculature (7% ± 5.4 reduc-
tion, p=0.0123) and reduced vessel density (9% ± 4.4 reduction, p=0.0002) (Figure 2G,H). Tazfl/fl
Pdgfb-iCreERT2 mice (Taz iEC-KO) did not show altered radial expansion but displayed decreased
vessel density (6% ± 5.8 reduction, p=0.0214) (Figure 2HG). Neither mutant showed a change in the
branching frequency of vessels (Figure 2I). Interestingly, in Yap iEC-KO retinas the expression of
TAZ was increased and TAZ more often localised to the nucleus (Figure 2—figure supplement 2),
suggesting compensatory regulation. Taz iEC-KO retinas did not however show a clear difference in
YAP expression (data not shown). Deleting both proteins in compound mutant mice (Yapfl/fTazfl/
flPdgfb-iCreERT2, YapTaz iEC-KO) led to a dramatic defect in blood vessel development (Figure 2E,
F): the retinal vasculature showed a 21% (±14, p=0.0012) decrease in radial expansion (Figure 2G), a
26% (±7.0, p<0.0001) decrease in capillary density (Figure 2H), and a 55% (±15.4, p<0.0001)
decrease in branching frequency (Figure 2I). Interestingly, the vessel loops were not only bigger in
Yap/Taz iEC-KO mice (Figure 2J), but also more variable in size (Figure 2K), and shape (Figure 2L)
than in control mice. These results indicate that endothelial YAP and TAZ are critical for the develop-
ment of a homogeneous blood vessel network and can perform redundant functions in the
endothelium.
YAP is required for endothelial cell proliferation in response to
mechanical stretch
As YAP and TAZ display pro-proliferative and anti-apoptotic roles in many cell types (Piccolo et al.,
2014; Meng et al., 2016), we evaluated whether the reduced vascularization of Yap/Taz iEC-KO ret-
inas was associated with reduced cell proliferation or increased apoptosis. EC proliferation, assessed
by EdU staining (Figure 3A–C), was decreased in Yap iEC-KO retinas (23% ± 10.0, p=0.0469), whilst
not affected in Taz iEC-KO. Consistent with our prior results the decrease in cell proliferation was
strongest in Yap/Taz iEC-KO retinas (33% ± 26.0, p=0.0059). Staining for cleaved caspase 3 revealed
that apoptosis was unaffected by YAP/TAZ loss (Figure 3D–F).
To understand if YAP and TAZ were required for proliferation downstream of VEGF, we knocked
down YAP and TAZ in human umbilical vein endothelial cells (HUVECs) using small interfering RNAs
(siRNAs) (Figure 3—figure supplement 1) and measured the proliferation rate by flow cytometry
after treatment with increasing concentrations of VEGF (Figure 3G). Interestingly, upon loss of YAP,
TAZ or YAP/TAZ, ECs proliferated at similar or even increased rates compared to control cells.
Figure 1 continued
marker ERG (red). White dotted lines, outline of endothelial nuclei. Yellow dotted lines, outline of perivascular
cells’ nuclei. Green arrowheads, nuclear localisation of YAP and TAZ. Red arrowheads, cytoplasmic localisation of
YAP and TAZ. Yellow arrowheads, junctional localisation of YAP and TAZ. Images correspond to single confocal
planes. n > 3 animals for each staining. Scale bar: 10 mm.
DOI: https://doi.org/10.7554/eLife.31037.002
The following figure supplement is available for figure 1:
Figure supplement 1. YAP and TAZ localise at endothelial adherens junctions in the mouse retina.
DOI: https://doi.org/10.7554/eLife.31037.003
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Figure 2. Endothelial YAP and TAZ are required for vessel growth, branching and homogeneity of the plexus. (A–
F,) Retinas from P6 Yap iEC-KO (B), Taz iEC-KO (D) and YapTaz iEC-KO (F), and respective control pups (A,C,E)
were stained with Isolectin B4 (IB4). Scale bar: 200 mm. (G–J), Quantification of radial expansion (G), vessel density
(H), branching frequency (I) and area of vessel loops (J) in Yap iEC-KO, Taz iEC-KO and YapTaz iEC-KO. Results
Figure 2 continued on next page
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Furthermore, VEGF treatment did not alter the subcellular localisation of YAP and TAZ in HUVECs
(Figure 3—figure supplement 2), suggesting that VEGF is not a primary regulator of their activity.
We next asked whether YAP and TAZ mediate endothelial proliferation in response to stretch –
another crucial mitogenic stimulus for the endothelium (Liu et al., 2007). To this end, we subjected
HUVECs to 24 hr of stretch and measured the proliferation rate in comparison to non-stretched,
static cells treated with the same siRNAs, by EdU labelling (Figure 3H). Control cells responded to
stretch with a 5-fold average increase in proliferation, and this effect was reduced upon knockdown
of VE-Cadherin confirming previous observations (Liu et al., 2007). The knockdown of YAP, but not
of TAZ, led to a significant decrease in stretch-induced proliferation. The knockdown of YAP/TAZ
showed a tendency to decreased proliferation in response to stretch but did not reach statistical sig-
nificance. Thus YAP is required for endothelial cell proliferation in response to mechanical stimula-
tion at cell-cell junctions.
YAP/TAZ loss leads to irregular endothelial cell distribution and
haemorrhages
Further analysis of Yap/Taz iEC-KO retinas revealed severe defects at the sprouting front. Yap/Taz
iEC-KO mutant retinas had 23% (±12.3, p=0.0113) fewer angiogenic sprouts than the control
(Figure 4A,B yellow asterisks and Figure 4—figure supplement 1). Moreover, whereas control
sprouts were elongated and showed long cellular protrusions towards the non-vascularised front
(Figure 4A’), sprouts in Yap/Taz iEC-KO retinas were rounder and lacked protrusions (Figure 4B’).
The defective sprout morphology correlated with irregular spacing and frequent aggregations of
ECs within the sprouts (Figure 4B’), arguing that migration and/or the rearrangement of ECs are
perturbed in Yap/Taz mutant vessels. Additionally, the Yap/Taz iEC-KO vasculature displayed aber-
rant vessel crossings (Figure 4C,C’,C”,D,D’,D”), suggesting that vessels may frequently have failed
to anastomose or stabilize connections following sprouting, and instead passed each other. Interest-
ingly, defects in cellular rearrangements, sprouting elongation and anastomosis have previously
been associated with altered stability or dynamics of endothelial cell junctions (Sauteur et al., 2014;
Bentley et al., 2014; Giannotta et al., 2013; Lenard et al., 2013; Dejana et al., 2008). The defects
in vessel morphology were coupled to defects in function as Yap/Taz iEC-KO retinas displayed large
haemorrhages from sprouts at the angiogenic front (Figure 4E,E’,F,F’), indicating loss of junctional
integrity.
Together, these results argue against the cell proliferation defect being the sole driver of the
Yap/Taz iEC-KO phenotype and suggest that endothelial YAP/TAZ play a role in the regulation of
EC junctions.
YAP/TAZ regulate adherens junction morphology and stability
Staining for VE-Cadherin revealed several junctional alterations in Yap/Taz iEC-KO vessels
(Figure 4G–H). In control retinas, cell junctions were thin and mostly linear (Figure 4G’), while in
Figure 2 continued
are shown as percentage of the respective controls. Data are mean ±SD. n  5 pups. p values were calculated
using unpaired t-test. *p<0.05; **p<0.01; ****p<0.0001. (K, L), Quantification of the standard deviation of the area
(K) and circularity (L) of the vessels loops in Yap iEC-KO, Taz iEC-KO and YapTaz iEC-KO retinas. Results are
shown as percentage of the respective controls. Data are mean ±SD. n  5 pups. p values were calculated using
unpaired t-test. *p<0.05; **p<0.01; ***p<0.001****p<0.0001.
DOI: https://doi.org/10.7554/eLife.31037.004
The following source data and figure supplements are available for figure 2:
Source data 1. Values for quantification of radial expansion (Figure 2G), vessel density (Figure 2H), branching fre-
quency (Figure 2I), area of gaps (Figure 2J) and standard deviation of area (Figure 2K) and circularity (Figure 2L)
of gaps in P6 Yap iEC-KO, Taz iEC-KO and YapTaz iEC-KO and respective control pups.
DOI: https://doi.org/10.7554/eLife.31037.007
Figure supplement 1. YAP and TAZ proteins are lost upon Cre-mediated genetic deletion in P6 mouse retinas.
DOI: https://doi.org/10.7554/eLife.31037.005
Figure supplement 2. TAZ compensates for the loss of YAP in endothelial cells in vivo.
DOI: https://doi.org/10.7554/eLife.31037.006
Neto et al. eLife 2018;7:e31037. DOI: https://doi.org/10.7554/eLife.31037 6 of 30
Research article Cell Biology Developmental Biology and Stem Cells
Figure 3. YAP and TAZ are required for endothelial cell proliferation in vivo and endothelial cell proliferation in response to mechanical stretch in vitro.
(A, B) P6 retinal vessels labelled with IB4 (grey) and stained for EdU (red, marking S phase positive cells) and Erg (green, marking endothelial nuclei) in
YapTaz iEC-KO (B) and littermate control mice (A). A’,B’, mask of Erg +cells indicating endothelial nuclei. (A’’, B’’) mask of Erg + and EdU + cells
indicating proliferating endothelial cells. (C) Quantification of endothelial proliferation in Yap iEC-KO (n = 3 control/4 KO pups), Taz iEC-KO (n = 5
control/5 KO pups) and YapTaz iEC-KO (n = 8 control/7 KO pups). Number of EdU-positive and ERG-positive cells per IB4 labelled vascular area was
calculated for each genotype and results are shown in percentage of the respective controls. Data are mean ±SD. p values were calculated using
unpaired t-test. ns, p>0.05; *p<0.05; **p<0.01. Scale bar: 50 mm. (D, E) P6 retinal vessels labelled with IB4 (grey) and stained for cleaved caspase 3 (red)
in YapTaz iEC-KO (E) and littermate control mice (D).D’, E’, magnification of boxed area in D,E. Red arrowheads, cleaved caspase 3 positive endothelial
cell. Black arrowheads, cleaved caspase 3 outside vessels. D’’,E’’, mask of cleaved caspase 3 positive endothelial cells. (F) quantification of endothelial
apoptosis in Yap iEC-KO (n = 7 control/7 KO pups), Taz iEC-KO (n = 4 control/4KO pups) and YapTaz iEC-KO (n = 5 control/4 KO pups). Data are
mean ±SD. p values were calculated using unpaired t-test. ns, p>0.05. Scale bar: D-E 100 mm, D’-E’ 50 mm. (G) Quantification of endothelial proliferation
with increasing concentrations of VEGF treatment in YAP, TAZ and YAP/TAZ knockdown cells and control. HUVECs were treated with 0, 40, 200 or 1000
ng/mL VEGF for 24 hr and the percentage of cells in S phase was determined by flow cytometry. Graph shows the mean +SD fold change in
percentage of S phase positive cells relative to 0 ng/mL of VEGF treatment. n = 3 independent experiments;>50.000 cells analysed per experiment per
condition. (H) Quantification of endothelial proliferation after stretch in in YAP, TAZ, YAP/TAZ and VE-Cadherin knockdown cells and control. HUVECs
were subjected to cyclic stretch for 24 hr and percentage of cells in S phase was determined by EdU pulsing and immunofluorescence staining. Graph
shows the mean +SD fold change in percentage of S phase positive cells of stretched to non stretched cells for each knockdown condition. n = 5
independent experiments, >100 cells counted per experiment per condition. p values were calculated using unpaired t-test. ns, p>0.05; *p<0.05.
DOI: https://doi.org/10.7554/eLife.31037.008
Figure 3 continued on next page
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Yap/Taz iEC-KO retinas ECs displayed tortuous junctions (Figure 4H’). VE-Cadherin staining also
unveiled profound differences in the arrangement of ECs within vessels. In control retinas, ECs were
Figure 3 continued
The following source data and figure supplements are available for figure 3:
Source data 1. Values for quantification of endothelial proliferation (Figure 3C) and apoptosis (Figure 3F) in P6 Yap iEC-KO, Taz iEC-KO and YapTaz
iEC-KO and respective control pups.
DOI: https://doi.org/10.7554/eLife.31037.011
Figure supplement 1. YAP and TAZ proteins are lost after gene knockdown by siRNA in HUVECs.
DOI: https://doi.org/10.7554/eLife.31037.009
Figure supplement 2. VEGF treatment does not affect YAP and TAZ subcellular localisation.
DOI: https://doi.org/10.7554/eLife.31037.010
Figure 4. Combined loss of YAP and TAZ leads to decreased sprouting numbers and shape defects, vessel crosses, haemorrhages at the sprouting
front and adherens junctions’ defects in vivo. (A, B) P6 retinal vessels labelled with IB4 (green) and stained for ERG (magenta, marking endothelial
nuclei) in YapTaz iEC-KO (B) and littermate control mice (A). Yellow asterisks mark sprouts. A’,B’, magnification of boxed areas in A and B. n = 9
control/9 KO pups. Scale bar: A,B 100 mm, A’, B’ 25 mm. (C, D) P6 retinal vessels labelled with IB4 in YapTaz iEC-KO (D) and littermate control mice (E).
Red arrowheads, vessel crosses. (C’, D’) magnification of boxed areas in C,D. C’’,D’’, depiction of vessels in C’ and D‘; different colours represent
vessels in different 3D planes. n = 4 control/4 KO pups. Scale bar: C,D 100 mm, C’-D’ 20 mm. (E, F) P6 retinal vessels labelled with IB4 (green) and
stained for TER119 (magenta, marking red blood cells) in YapTaz iEC-KO (F) and littermate control mice (E). Red arrowheads, haemorrhages. E’,F’,
magnification of boxed areas in E and F. n = 4 control/5 KO pups. Scale bar: E,F 1000 mm, E’, F’ 100 mm. (G, H), P6 retinal vessels labelled with IB4
(green) and stained for VE-Cadherin (magenta) in YapTaz iEC-KO (H) and littermate control mice (G). Red arrowheads, no longitudinal VE-Cadherin
labelled junction along vessel axis denoting unicellular vessel segments. (G’,H’, G’’,H’’) magnification of boxed areas in G and H. n = 4 control/4 KO
pups. Scale bar: G,H 25 mm, G’,H’ 5 mm, G”,H” 10 mm.
DOI: https://doi.org/10.7554/eLife.31037.012
The following figure supplement is available for figure 4:
Figure supplement 1. Combined loss of YAP and TAZ leads to decreased number of sprouts in the developing mouse retina.
DOI: https://doi.org/10.7554/eLife.31037.013
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arranged into multicellular tubes, highlighted by the presence of two or more VE-Cadherin junctions
running longitudinally along the axis of the vessels (Figure 4G,G’’). Some unicellular segments lack-
ing VE-Cadherin staining could also be found and always correlated with decreasing calibre, indica-
tive of regressing vessels (Figure 4G red arrowheads) (Franco et al., 2015). In contrast, in Yap/Taz
iEC-KO retinas we observed many unicellular vessel segments lacking longitudinal VE-Cadherin junc-
tions, but in vessels of normal calibre (Figure 4H, red arrowheads and H’’). As junctional remodelling
has been shown to be required for the cellular rearrangements that establish multicellular tubes
(Sauteur et al., 2014), these results suggest that YAP and TAZ regulate junctional remodelling.
VE-Cadherin staining in HUVECs after YAP, TAZ and YAP/TAZ knockdown further revealed
altered junctional morphologies compared to control cells. Previous studies have correlated junc-
tional morphology with cellular activities. In vivo, straight or linear junctions were associated with
high Notch activity and stalk cell behaviour, while serrated junctions (also referred to as VE-Cadherin
fingers) were found in tip cells or actively rearranging cells (Bentley et al., 2014). In vitro, VE-Cad-
herin fingers were shown to steer migrating ECs and couple leader and follower cells (Hayer et al.,
2016), and have also been correlated with increased permeability in cell monolayers. More recently,
junction associated intermediate lamellipodia (JAIL) have been identified in the sprouting vessels of
the mouse retina, and linked to increased migration (Cao et al., 2017) as well as decreased perme-
ability in cultured ECs (Breslin et al., 2015).
To more accurately describe the differences in junctional morphology after YAP/TAZ knockdown,
we defined five junctional categories: straight junctions, thick junctions, thick to reticular junctions,
reticular junctions and fingers (Figure 5E). Live imaging analysis of VE-Cadherin-GFP transduced
HUVECs showed that reticular junctions correspond to JAIL, and thick to reticular junctions to small
JAIL. (Figure 5—video 1). Whereas control cells showed mostly reticular junctions (Figure 5A,F),
the knockdown of YAP and TAZ led to an increase in straight junctions and fingers, respectively
(Figure 5B,C,F). The combined knockdown of YAP/TAZ led to an increase in both straight junctions
and fingers and to a loss of reticular junctions (Figure 5D,F). In addition, the knockdown of YAP/TAZ
led to junctional breaks in the monolayer, as seen by the presence of gaps in VE-Cadherin stainings
(Figure 5D, red arrowheads). Together, these observations demonstrate that YAP and TAZ together
are required for the formation of JAIL and reduce the formation of straight junctions and fingers.
To understand whether this shift in morphology translated into a functional defect, we investi-
gated the permeability of the monolayer to 250 kDa dextran molecules. Only the combined knock-
down of YAP/TAZ led to a significant increase in permeability in comparison to the control situation
(Figure 5G), suggesting that YAP/TAZ are both required for the barrier function of the endothelium
and can compensate for each other in this particular role.
The dynamic rearrangements of ECs during sprouting require that cell-cell junctions are con-
stantly assembled, rearranged and disassembled. To understand whether YAP and TAZ regulate the
turnover of cell junctions, we pulse-labeled VE-Cadherin molecules at cell junctions using an anti-
body directly coupled to a fluorescent dye for 30 min (Figure 5H–I) (Dorland et al., 2016). The anti-
body was subsequently washed out and cells cultured for two more hours in normal conditions,
before being fixed and stained for surface VE-Cadherin using a second fluorescent label. Comparing
the two sequential VE-cadherin labels allowed us to distinguish junctions with high, intermediate and
low turnover rates (Figure 5J). In control cells, 44% of patches were of high turnover junctions, 24%
of intermediate turnover junctions and 32% of low turnover junctions (Figure 5K). The knockdown of
YAP/TAZ significantly decreased the percentage of high turnover junctions to 14% (p=0.0387) and
increased the percentage of low turnover junctions to 58%. Interestingly, we found a correlation
between the morphology of junctions and VE-Cadherin turnover rates (Figure 5L): straight junctions
and fingers showed the lowest turnover rate, while reticular junctions showed the highest. To under-
stand if the different VE-Cadherin turnover observed after knockdown of YAP/TAZ was caused by a
shift in morphology, we compared the turnover of VE-Cadherin within the same morphological cate-
gories. Knockdown of YAP/TAZ decreased the percentage of high turnover junctions within all mor-
phological categories, confirming a specific defect in VE-Cadherin turnover. To further investigate
how YAP and TAZ affect the turnover of VE-cadherin, we transfected HUVECs with a photo-convert-
ible fluorescent protein tagged VE-Cadherin (VE-cadherin-mEos3.2) and measured the fluorescence
loss after photo conversion in straight junctions. The knockdown of YAP/TAZ led to a significant
increase in the amount of immobile VE-cadherin-mEos3.2 at the junctions (Figure 5M) without signif-
icantly affecting the half time of fluorescence loss of the mobile fraction (Figure 5N). Together,
Neto et al. eLife 2018;7:e31037. DOI: https://doi.org/10.7554/eLife.31037 9 of 30
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Figure 5. YAP and TAZ regulate adherens junctions’ morphology, monolayer permeability and VE-Cadherin turnover in vitro. (A–D) HUVECs knocked
down for YAP (B), TAZ (C) and YAP/TAZ (D) and control (A) stained for VE-Cadherin. Red arrowheads, discontinuous VE-Cadherin. Scale bar: 50 mm. (E)
Representative patches used for manual morphological classification of adherens junctions in five categories: straight junctions, thick junctions, thick to
reticular junctions, reticular junctions and fingers. (F) Morphological analysis of VE-Cadherin labelled cell junctions in HUVECs knocked down for YAP,
TAZ and YAP/TAZ. Data are mean percentage ±SD of 3 independent experiments (two for siTAZ). n > 140 patches of VE-Cadherin stained HUVECs per
knockdown condition per experiment. p values were calculated using unpaired t-test between knocked down cells for YAP, TAZ and YAP/TAZ and
control. *p<0.05; **p<0.01. (G) Permeability of YAP, TAZ and YAP/TAZ knockdown monolayers of HUVECs to 250 kDa fluorescent dextran molecules.
Data are mean +SD of 3 independent experiments. p values were calculated using unpaired t-test between knocked down cells for YAP, TAZ and YAP/
TAZ and control. RFU, relative fluorescence units. *p<0.05. (H, I) HUVECs knocked down for YAP/TAZ (I) and control (H) triple labelled with DAPI (blue),
pulsed VE-Cadherin 55-7HI (red, VE-Cadherin pulse), and surface VE-Cadherin (green, VE-Cadherin staining). VE-Cadherin 55-7HI pulse was done for 30
min and cells were fixed 2 hr after end of pulse. Scale bar: 20 mm. (J) Representative patches used for manual classification of junctions into high,
intermediate and low turnover. (K) Quantification of junctional turnover in YAP/TAZ knockdown cells and control. (L) Quantification of the percentage of
high turnover junctions in each morphological category in YAP/TAZ knockdown cells and control. (K, L) Data are mean ±SD of 3 independent
experiments. n > 70 patches per knockdown condition per experiment. Fewer then five patches were reticular in YAP/TAZ knockdown, not allowing for
reliable assessment of percentages between high, intermediate and low turnover. p values were calculated using unpaired t-test. *p<0.05. (M, N)
Fluorescence loss after photoconversion of VE-Cadherin mEos in straight junctions of YAP/TAZ knockdown HUVECs and control HUVECs. M, VE-
Cadherin mEos immobile fraction. N, VE-Cadherin mEos half-life of fluorescence loss. Data are mean ±SD of 3 independent experiments. n = 15 control
cells and 16 cells YAP/TAZ knockdown cells. p values were calculated using unpaired t-test between knocked down cells for YAP/TAZ and control.
Figure 5 continued on next page
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these results show that YAP/TAZ increase the turnover of adherens junctions by increasing the pool
of mobile VE-Cadherin.
Immunofluorescence staining for f-actin in YAP/TAZ deficient cells (Figure 5P,P’) showed an
increase in actin bundles (actin filaments along the junction and stress fibers) and a decrease in
branched actin networks, in comparison with control cells (Figure 5O,O’). This result correlates with
the junctional morphologies observed before, as straight junctions and fingers associate respectively
with actin filaments and stress fibers (Abu Taha and Schnittler, 2014), while JAILs associate with
branched actin (Abu Taha et al., 2014). Interestingly, our VE-Cadherin pulse labeling experiments
showed that the junction morphologies with less turnover, straight junctions and fingers, were the
ones associated with bundled actin filaments, while the morphologies with higher turnover, reticular
junctions, associated with branched actin networks.
As cell junctions and the actin cytoskeleton are essential for ECs to rearrange and migrate collec-
tively (Vitorino and Meyer, 2008), and Yap/Taz iEC-KO retinas presented less elongated sprouts
suggestive of a migration defect, we asked whether cell migration was also regulated by YAP/TAZ.
YAP/TAZ are required for individual endothelial cell migration
To address the requirement of YAP and TAZ for endothelial cell migration, we performed scratch-
wound assays (Figure 6A–H). While in the control situation the wound was completely closed at 16
hr (Figure 6A,B,I), less than 50% of the wound area was closed after YAP knockdown at the same
time point (p<0.0001) (Figure 6C,D,I). A stronger effect on endothelial cell migration was observed
after the knockdown of TAZ and YAP/TAZ, with less than 20% of the wound area being closed
(p<0.0001 for siTAZ vs siCTR and for siYAP +siTAZ vs siCTR) (Figure 6E,F,G,H,I).
Given that cells aggregated at the sprouting front of Yap/Taz iEC-KO retinas, we wondered
whether in addition to defective directional cell migration they also lacked the ability to shuffle with
the neighbouring cells. Recent data illustrated that collectively migrating ECs in vitro move in
streams and swirls and display straight junctions along the lateral boundaries and fingers along the
front and rear (Hayer et al., 2016). To investigate collective cell migration we therefore analysed
the arrangement of cells in a confluent monolayer (Figure 6J–O). Control cells displayed a cobble-
stone appearance without identifiable subgroups of cells (Figure 6J). In contrast, after knockdown
of YAP/TAZ cells adopted elongated shapes and arranged into streams and swirls (Figure 6K). To
quantity this effect we used the longest axis of the EC nucleus as a proxy for the orientation of each
cell and developed a measure of monolayer coordination based on the alignment of cells with their
neighbours (Figure 6L,L’,M,M’, N). A score of 1 would signify parallel alignment between all cells,
and a score of 0 random alignment of the population. Control cells displayed higher than random
alignment with their closest neighbours, but cells beyond 300 mm from each other were arranged at
random (Figure 6I). While the knockdown of YAP did not affect the alignment score of cells, the
knockdown of TAZ led to increased alignment. The combined knockdown of YAP/TAZ led to an
even higher degree of coordination, with higher alignment scores across all distances between cells.
These results suggest that YAP/TAZ promote the ability of cells to distribute individually within
monolayers.
Figure 5 continued
**p<0.01. (O, P) HUVECs knocked down for YAP/TAZ (P) and control (O) double stained for VE-Cadherin (red) and f-actin (green, phalloidin). (O’, P’)
f-actin (black, phalloidin). Scale bar: 50 mm.
DOI: https://doi.org/10.7554/eLife.31037.014
The following video and source data are available for figure 5:
Source data 1. Values for quantification of morphological (Figure 5F) and junctional turnover (Figure 5K) analysis of VE-Cadherin in HUVECs knocked
down for YAP, TAZ and YAP/TAZ.
DOI: https://doi.org/10.7554/eLife.31037.015
Figure 5—video 1. Reticular junctions correspond to junction associated intermediate lamellipodia.
DOI: https://doi.org/10.7554/eLife.31037.016
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Nuclear YAP and TAZ inhibit Notch and BMP signalling in endothelial
cells
To gain insight into the nuclear function of YAP and TAZ, we generated a Pdgfb-iCreERT2 -inducible
TAZ gain-of-function mouse allele, in which a mutated version of TAZ (TAZ S89A) is introduced in
the Rosa26 locus and expressed by a CAG promoter following Cre-mediated excision of an
upstream stop cassette (Figure 7—figure supplement 1). The serine-to-alanine mutation in TAZ
results in enhanced nuclear TAZ localization as it escapes phosphorylation by the upstream Hippo
kinase cascade (Varelas et al., 2010). The allele also expresses nuclear EGFP by means of an IRES
sequence, allowing the identification of recombined cells expressing the TAZ mutant protein. Taz
iEC-GOF retinas exhibited 25% increased sprouting (±12.2, p=0.0074) (Figure 7A,B yellow asterisks
and Figure 7C) and 19% increased branching (±8.3, p=0.0012) (Figure 7D). Thus, driving nuclear
TAZ expression leads in many aspects to the opposite phenotype of Yap/Taz iEC-KO retinas, sug-
gesting that the loss of the nuclear function of YAP/TAZ plays a key role in the development of the
observed vascular loss-of-function phenotypes.
To elucidate the transcriptional targets of YAP and TAZ, we performed unbiased transcriptome
analysis on HUVECs transduced with adenoviruses encoding for YAP and TAZ gain-of-function
mutants or GFP as a control (AdYAPS127A, AdTAZS89A, AdGFP) (Figure 7—figure supplement 2).
Figure 6. YAP and TAZ are required for uncoupled, individual cell migration. (A–H), Phase contrast images of YAP (C,D), TAZ (E,F) and YAP/TAZ (G,H)
knockdown HUVECs and control (A,B) immediately after removing barrier to create a cell free space (A,C,E,G) and 16 hr later (B,D,F,H). (I),
Quantification of wound closure at 16 hr. Data are mean ±SD of 3 independent experiments (8–9 biological replicates). p values were calculated using
unpaired t-test between knocked down cells for YAP, TAZ or YAP/TAZ and control. ****p<0.0001. (J, K), Phase contrast images of YAP/TAZ knockdown
monolayer of HUVECs (K) and control (J). (L, M), Fluorescence labelling of nuclei with DAPI of YAP/TAZ knockdown monolayer of HUVECs (M) and
control (L). Scale bar: 100 mm. (L’,M’) Longest axis of nuclei. (N) Alignment score between nuclei pairs used for quantification of cell coordination in O.
Angles made by the nuclei longest axis of a pair of nuclei were calculated; angles of 0, 45 and 90 degrees scored 1,0 and  1 in alignment. (O)
Coordination plot of monolayers of HUVECs knocked down for YAP, TAZ and YAP and TAZ and control. Graph shows mean alignment score of all pairs
of cells in the monolayer plotted against distance between them. Randomly aligned cells score 0 in mean alignment. n = 3 independent experiments,
>10.000 pairs of nuclei analysed per knockdown condition per experiment.
DOI: https://doi.org/10.7554/eLife.31037.017
The following source data is available for figure 6:
Source data 1. Values for quantification of wound closure at 16 hr in YAP, TAZ and YAP/TAZ knockdown HUVECs and control (Figure 6I).
DOI: https://doi.org/10.7554/eLife.31037.018
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Figure 7. Nuclear YAP and TAZ inhibit Notch and BMP signalling in endothelial cells. (A–B) Retinas from P6 Taz iEC-GOF (B) and control pups (A) were
stained for the endothelial marker PECAM (blue) and the endothelial nuclei marker ERG (red). Taz iEC-GOF mice express mosaically nuclear EGFP
(nEGFP, green) marking cells expressing the TAZ gain of function mutation TAZS89A. Yellow asterisks mark sprouts. Images correspond to maximum
projection of z stack. Scale bar: 50 mm. (C) Quantification of number of sprouts per 100 mm of sprouting front extension at P6 in Taz iEC-GOF mice
(n = 6 pups) and littermate control mice (n = 6 pups). Data are mean ±SD. p values were calculated using unpaired t-test. **p<0.01. (D) Quantification
of branching frequency (i.e. number of branching points per field of view) in Taz iEC-GOF mice (n = 6 pups) and littermate control mice (n = 6 pups).
Data are mean ±SD. p values were calculated using unpaired t-test. **p<0.01. (E), Reverse transcriptase PCR of HUVECs transduced with adenoviruses
carrying YAP (AdYAP) and TAZ (AdTAZ) constitutively active forms and control (AdGFP). Data are mean ±SD of 3 independent experiments. p values
were calculated using unpaired t-test between AdGFP and AdYAP or AdTAZ. *p<0.05; **p<0.01; ***p<0.001; ****p<0.0001. (F) Reverse transcriptase
PCR of YAP/TAZ knockdown HUVECs and control. Data are mean ±SD of 3 independent experiments. p values were calculated using unpaired t-test.
*p<0.05; **p<0.01; ***p<0.001; ****p<0.0001. (G,H), P6 retinal vessels labelled with IB4 (green) and stained for DLL4 (magenta) in YapTaz iEC-KO mice
(H) and littermate control mice (G). Images correspond to maximum projection of z stack. Scale bar: 50 mm. (I,J), P6 retinal vessels labelled with IB4
(blue) and stained for ERG (red, marking endothelial nuclei) and pSMAD1/5/8 (green) in YapTaz iEC-KO (J) and littermate control mice (I). Images
correspond to single confocal planes. (I’,J’) magnification of boxed areas in I and J. Red arrowheads, endothelial nuclei negative for pSMAD1/5/8.
Green arrowheads, endothelial nuclei positive for pSMAD1/5/8. Scale bar: I,J 50 mm, I’, J’ 10 mm. (K) Quantification of endothelial cells positive for
pSMAD1/5/8 at the sprouting front of the P6 retina in YapTaz iEC-KO (n = 3 pups) and littermate control mice (n = 3 pups). Data are mean
percentage ±SD. p values were calculated using unpaired t-test. ****p<0.0001.
DOI: https://doi.org/10.7554/eLife.31037.019
The following source data and figure supplements are available for figure 7:
Figure 7 continued on next page
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Forced activation of YAP and TAZ led to congruent gene expression changes including the canonical
YAP/TAZ target genes CYR61, ANKRD1, and CTGF, as expected. Interestingly, YAP and TAZ also
suppressed numerous Notch and BMP target genes. During sprouting angiogenesis, Notch and
BMP9/10 signalling restrict the acquisition of a tip cell phenotype by activated ECs
(Hellstro¨m et al., 2007; Lobov et al., 2007; Suchting et al., 2007; Siekmann and Lawson, 2007;
David et al., 2008; Larrive´e et al., 2012; Laux et al., 2013). These results were confirmed by qRT-
PCR analysis (Figure 7E): AdYAPS127A and AdTAZS89A cells expressed significantly less LFNG, DLL4
and HES1 (Notch target genes), SMAD6, UNC5B and ID1 (BMP target genes) and HEY1 (a common
Notch and BMP target gene) than control cells. Consistent with these findings, knockdown of YAP
or TAZ lead to a substantial increase in Notch reporter activity (Figure 7—figure supplement 3A)
and target gene expression (Figure 7F). Similar effects were observed for the BMP pathway (Fig-
ure 7—figure supplement 3B and Figure 7F), while TEAD-driven reporter activity and YAP/TAZ tar-
get genes were repressed (Figure 7—figure supplement 3C and Figure 7F).
To understand if Notch and BMP signalling were also affected in vivo, we stained Yap/Taz iEC-
KO retinas for DLL4 and phospho-SMAD1/5/8. In control retinas, DLL4 expression was highest at the
leading edge, decreasing over the first 100 mm from the sprouting front, beyond which the expres-
sion was evenly low throughout the vessels in the plexus (Figure 7G,H and Figure 7—figure supple-
ment 4). In Yap/Taz iEC-KO retinas the expression of DLL4 at the sprouting front was higher;
additionally, the area of high DLL4 was broader, decreasing for up to 200 mm from the sprouting
front before flattening to the lower levels of the plexus. Moreover, staining Yap/Taz iEC-KO retinas
for pSMAD1/5/8 showed a ~ 10 fold increase in the number of ECs positive for pSMAD1/5/8 at the
sprouting front (p<0.0001) (Figure 7I,I’, J,J’,K).
Together, these results identify that endothelial YAP and TAZ repress Notch and BMP signalling
during angiogenesis and retinal vascular expansion.
Inhibition of BMP signalling partially rescues the cellular defects of
YAP/TAZ loss in endothelial cells
To address whether the Notch or BMP signalling increase were responsible for the cellular defects
of YAP/TAZ deficiency, we used different inhibitors to manipulate Notch and BMP signalling in cul-
tured cells. Treatment with the Notch inhibitor DBZ corrected the Notch reporter activity increase
after YAP and TAZ knockdown in HUVECs (Figure 8A), but did not affect the migration of cells in
the scratch wound assay (Figure 8B).
To decrease BMP signaling we screened several inhibitors targeting different BMPs or BMP
receptors (Figure 8C, Supplementary file 1). Only Ldn193187, an Alk2/3/1 kinase inhibitor, signifi-
cantly decreased the BMP reporter activity after YAP and TAZ knockdown (p=0.0063) (Figure 8D).
In comparison to control cells, the BMP reporter activity in YAP/TAZ deficient cells was 12 times
higher, dropping to seven times higher after Ldn193187 treatment. To understand if the partial BMP
rescue altered the cellular defects after YAP/TAZ loss, we performed the scratch wound and perme-
ability assays using this inhibitor. Ldn193187 treatment partially rescued the migration defect of
YAP/TAZ knockdown HUVECs in the scratch wound assay, significantly increasing the wound closure
at 16 hr from 33 ± 3% in DMSO treated cells to 56 ± 5% in Ldn193187 treated cells (p=0.0022)
(Figure 8E). Ldn193187 treatment fully rescued the permeability defect of YAP/TAZ knockdown
HUVECs to 250 kDa FITC dextran molecules (Figure 8F). Staining for VE-Cadherin further showed
Figure 7 continued
Source data 1. Values for quantification of number of sprouts (Figure 7C) and branching frequency (Figure 7D) in Taz iEC-GOF mice and controls.
DOI: https://doi.org/10.7554/eLife.31037.024
Figure supplement 1. Targeting strategy used for the generation of the conditional TAZ gain-of-function mouse model.
DOI: https://doi.org/10.7554/eLife.31037.020
Figure supplement 2. Microarray of YAP and TAZ gain of function mutant cells.
DOI: https://doi.org/10.7554/eLife.31037.021
Figure supplement 3. YAP and TAZ knockdown increases Notch and BMP reporter activities in vitro.
DOI: https://doi.org/10.7554/eLife.31037.022
Figure supplement 4. DLL4 intensity in YapTaz iEC-KO.
DOI: https://doi.org/10.7554/eLife.31037.023
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Figure 8. BMP inhibition partially rescues the cellular defects of YAPTAZ knockdown HUVECs. (A) Luciferase reporter assay for Notch activity in YAP/
TAZ knockdown HUVECs and controls treated with 0.1 mM DBZ or DMSO. Data are mean ±SEM. p values were calculated using unpaired t-test. n  3
biological replicates. (B) Quantification of wound closure at 16 hr for HUVECs knocked down for YAP/TAZ and treated with 0.1 mM DBZ or DMSO. Data
are mean ±SD. p values were calculated using unpaired t-test. n = 6 biological replicates. (C) Schematic of the BMP inhibitors used depicting
preferential sites of inhibition. Alk1fc, ENGecd and Gremlin preferentially bind extracellular BMPs. K02288 and Ldn193189 are kinase inhibitors. (D)
Luciferase reporter assay for BMP activity in YAP/TAZ knockdown HUVECs and controls treated with 25 ng/mL Alk1fc, 0.25 mg/mL ENGecd, 0.1 mg/mL
Gremlin, 1 mM K02288, 1 mM Ldn193189 and DMSO. Data are mean ±SEM. p values were calculated using unpaired t-test. n  3 biological replicates.
(E) Quantification of wound closure at 16 hr for HUVECs knocked down for YAP/TAZ and treated with 1 mM Ldn193189 or DMSO. Data are mean ±SD.
p values were calculated using unpaired t-test. n = 6–7 biological replicates. (F) Permeability of HUVECs knocked down for YAP/TAZ and treated with 1
mM Ldn193189 or DMSO to 250 kDa fluorescent dextran molecules. Data are mean ±SD. RFU, relative fluorescence units. p values were calculated using
unpaired t-test. n = 6 biological replicates. (G, H) HUVECs knocked down for YAP/TAZ and treated with 1 mM Ldn193189 (H) or DMSO (G) stained for
VE-Cadherin. (G’, H’) different colours mark different cells. Red arrowheads, fingers. Red arrow, reticular junction. Scale bar G, H, 50 mm. Scale bar G’,
H’, 10 mm. (I) Morphological analysis of VE-Cadherin labelled cell junctions in HUVECs knocked down for YAP/TAZ and treated with 1 mM Ldn193189 or
Figure 8 continued on next page
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that Ldn193187 treatment decreased the frequency of finger junctions and increased the frequency
of JAIL in YAP/TAZ deficient cells (Figure 8G–H). Quantification of junction morphologies identified
that Ldn193187 treatment decreased the frequency of finger junctions in YAP/TAZ deficient cells to
the levels found in control cells (Figure 8I and Figure 5F, % of fingers: siYAP/TAZ DMSO, 25 ± 5%,
siYAP/TAZ Ldn193187 12 ± 0.6%, siCTR: 9 ± 4%). Ldn193187 treatment also led to a 3-fold increase
in thick to reticular (p=0.012) and reticular junctions (p=0.043) in YAP/TAZ knockdown cells. The fre-
quency of straight junctions was also significantly decreased (p=0.0326) although still remaining high
in comparison to control cells. Together, these results show that the BMP signaling increase is at
least partially involved in the cellular defects caused by YAP/TAZ deficiency.
To gain insight into how YAP and TAZ repress BMP signalling, we analysed the gene expression
of BMPs, BMP receptors and co-receptors and BMP antagonists in YAP and TAZ gain of function
mutant HUVECs (Figure 8—figure supplement 1). As YAP and TAZ function as transcriptional co-
activators, the direct targets of YAP and TAZ would be upregulated in this assay, while genes that
are downregulated would represent indirect regulation. Forced activation of YAP and TAZ led to
increased expression of the BMP ligands BMP2, BMP4 and BMP6, which cannot explain the increase
in BMP signalling in the loss of function condition. However, we also found increased expression of
the BMP antagonists FST, CTGF, BAMBI, SMURF2, NOG and SMURF1. Thus YAP and TAZ decrease
BMP signalling in endothelial cells possibly by increasing the expression of BMP inhibitors.
Together, these results suggest that YAP/TAZ repress BMP activation in endothelial cells, modu-
lating junctions and cell migration.
Discussion
The present study aimed to provide a detailed understanding of the distribution and function of
endothelial YAP and TAZ in angiogenesis. Our finding that YAP and TAZ were present in the nucleus
of ECs at the sprouting front of developing vessels shows parallels with other cell types where
nuclear YAP and TAZ are detected in actively proliferating areas of developing tissues. Interestingly,
however, YAP and TAZ show distinct expression patterns in ECs, although these proteins show a
high degree of redundancy in many other cell types. While TAZ was predominantly expressed in the
sprouting front where it accumulated strongly in endothelial nuclei, YAP was mostly cytoplasmic
both in the sprouting front and also in more mature, remodelling vessels. Interestingly, recent work
by Sakabe and colleagues showed that cytoplasmic YAP promotes endothelial cell migration
(Sakabe et al., 2017).
In addition to nuclear and cytoplasmic YAP and TAZ, we also detected junctional localization of
these proteins in retinal vessels. A previous study by Giampietro and colleagues (Giampietro et al.,
2015) has shown that endothelial YAP associates with adherens junction proteins at stable junctions
and that this prevents its nuclear accumulation and transcriptional activity. Whether this is also true
for TAZ has previously not been addressed. A sequestration of YAP and TAZ either in the cytoplasm
or bound to junctional proteins can potentially serve different and not necessarily mutually exclusive
roles: preventing their nuclear activity, keeping a pool of protein ready to shuttle to the nucleus and
drive gene expression, and having other cytoplasmic functions. It is not yet entirely clear what regu-
lates the subcellular localisation of YAP and TAZ in the developing vasculature. ECs at the sprouting
front and in more mature vessels have different adherens junctions, experience distinct levels of sig-
nalling from secreted angiogenic molecules and are exposed to different levels of shear stress by
Figure 8 continued
DMSO control. Data are mean ±SD. p values were calculated using unpaired t-test. n = 3 biological replicates; n  45 patches of VE-Cadherin stained
HUVECs per condition per replicate.
DOI: https://doi.org/10.7554/eLife.31037.025
The following source data and figure supplement are available for figure 8:
Source data 1. Values of luciferase reporter assays for Notch (Figure 8A) and BMP (Figure 8D) activity in YAP/TAZ knockdown HUVECs and controls
treated with Notch or BMP inhibitors.
DOI: https://doi.org/10.7554/eLife.31037.027
Figure supplement 1. Nuclear YAP and TAZ increase the expression of BMP inhibitors.
DOI: https://doi.org/10.7554/eLife.31037.026
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blood flow. In vitro, endothelial YAP and TAZ relocate to the nucleus upon disruption of cell junc-
tions or loss of VE-Cadherin (shown for YAP by Choi and colleagues (Choi et al., 2015) and con-
firmed in our analysis also for TAZ, data not shown). In the mouse retina vasculature, Cao and
colleagues (Cao et al., 2017) recently observed that endothelial cells at the sprouting front display
reduced relative VE-Cadherin concentration that promotes cell-cell junction dynamics and JAIL for-
mation. These observations nicely correlate with our own data showing the sprouting front as the
area of preferential nuclear YAP/TAZ. Furthermore, we did not find junctional localisation of YAP/
TAZ at the sprouting front, pointing to less sequestration of YAP/TAZ away from the nucleus by
more dynamics junctions. Together, these data provide additional strength to a model in which
reduced VE-Cadherin concentration at cell junctions may promote YAP and TAZ relocation to the
nucleus. In zebrafish, Nakajima and colleagues (Nakajima et al., 2017) showed that YAP nuclear
relocation correlated with lumenisation of sprouting vessels, and they attributed this to the effect of
shear stress on YAP. In the mouse retina, hemodynamic fluid laws predict that vessels at the sprout-
ing front experience very low levels of shear (Bernabeu et al., 2014), arguing against YAP and TAZ
being activated by shear in this model. Additionally, we found no difference in the subcellular local-
isation of YAP or TAZ between arteries and veins, that is, vessels that experience distinct shear stress
levels. However, it is possible that local and fast changes in shear stress levels are more relevant to
regulate YAP and TAZ than sustained shear. In support of this idea, YAP and TAZ appear not to
respond to 12 or 24 hr of laminar shear (Wang et al., 2016), but translocate to the nucleus after
only 10 min of laminar shear (Nakajima et al., 2017). Finally, although VEGF, a pro-angiogenic mole-
cule secreted by astrocytes at the avascular front, drives endothelial proliferation and migration, we
found no evidence for VEGF induced YAP and TAZ nuclear translocation, although others found
opposite results (Kim et al., 2017; Wang et al., 2017). Other pro-angiogenic molecules, either
locally produced or blood-borne, could regulate endothelial YAP and TAZ during development;
future work will help clarify these questions and how different chemical and mechanical stimuli come
together to regulate YAP and TAZ.
To address the cell autonomous role of YAP and TAZ we took advantage of an endothelial spe-
cific inducible Cre to inactivate YAP and/or TAZ genetically during angiogenesis. The mild pheno-
type of the single mutants in comparison to the drastic phenotype of the compound mutant
indicates functional redundancy in the endothelium. The compound loss of endothelial YAP and TAZ
leads in the mouse retina to a decrease in the radial expansion of vessels, vascular density, branching
and sprouting. This phenotype could be a consequence of a decreased number of ECs caused by a
proliferation defect (Ubezio et al., 2016). However, our further discovery that YAP and TAZ are
required to establish homogeneity in the plexus and prevent cellular aggregations suggests that
endothelial YAP/TAZ signalling is not only required to provide adequate numbers of cells but is also
critically involved in ensuring adequate EC distribution. We propose that endothelial YAP/TAZ oper-
ate in several mechanisms that jointly establish a balance of the right number of endothelial cells in
the right place. First, endothelial YAP/TAZ drive proliferation in response to mechanical stimulation
at the cell-cell junction, and not in response to VEGF. We propose that in this way endothelial YAP/
TAZ provide a cell intrinsic mechanism of locally controlling cell densities, in contrast to growth fac-
tor-mediated cell proliferation instructed by the surrounding tissue. Second, endothelial YAP/TAZ
increase VE-Cadherin turnover at cell-cell junctions, which we propose is essential for cells to migrate
and rearrange while maintaining the endothelial barrier at the same time. This corroborates recent
findings in mouse hepatocytes where YAP antagonises adherens junction stability (Bai et al., 2016).
The authors showed that YAP regulates hepatocyte adherens junctions in response to increased
actomyosin contractility by increasing myosin II light chain gene expression. Accordingly, the tran-
scriptional, nuclear role of YAP was required for junctional regulation. Together with our observa-
tions, these findings indicate the existence of a positive feedback loop where stable junctions
sequester YAP and TAZ from the nucleus, therefore maintaining less junctional turnover, while
remodelling junctions allow YAP and TAZ to relocate to the nucleus where they increase VE-Cad-
herin turnover. Our results also suggest that a high VE-Cadherin turnover at the sprouting front is
required in order to maintain junctional integrity and prevent bleedings. YAP and TAZ increase the
presence of JAIL (the more dynamic type of junction in our analysis) and promote branching of actin.
These results are in accordance with recent data from Sakabe and colleagues reporting that YAP
and TAZ increase Cdc42 activity in lamellipodia and phosphorylation of N-WASP (Sakabe et al.,
Neto et al. eLife 2018;7:e31037. DOI: https://doi.org/10.7554/eLife.31037 17 of 30
Research article Cell Biology Developmental Biology and Stem Cells
2017), an actin binding protein that promotes branching of actin through the activation of the Arp2/
3 complex.
Molecularly, how YAP and TAZ affect this complex cell behavior is not entirely clear. Our results
identify that endothelial YAP/TAZ reduce the expression of Notch and BMP signaling in ECs, yet the
in vitro rescue attempts show that the Notch increase is not the reason for the YAP/TAZ phenotype.
This is further corroborated by in vivo data from Kim and colleagues showing that DAPT treatment
fails to restore sprouting defects in YAP/TAZ mutant retinas (Kim et al., 2017). In contrast, reducing
the increased BMP signalling experimentally corrected the permeability, and partially restored cell
migration in YAP/TAZ deficient cells. This would suggest that BMP, not Notch, is a main driver of
the observed cellular phenotypes. Whether the increased BMP signalling is also responsible for the
phenotypes of YAP/TAZ loss of function in vivo remains to be shown. Furthermore, the full details of
the involved ligands and receptors of the BMP pathway remain to be determined. Previous studies
identified that BMP9/10 – Alk1 signalling is anti-angiogenic (Larrive´e et al., 2012), while BMP2/4/6 -
Alk2/Alk3 signalling is pro-angiogenic (Lee et al., 2017). Given the hyposprouting phenotype and
reduced cell migration, we expected an increase in BMP9/10-Alk1 signalling after YAP/TAZ loss.
However, the results from the panel of BMP inhibitors instead point towards a possible increase of
the BMP2/4 – ALK3 pathway activity. However, given the notorious promiscuity of chemical inhibi-
tors, and the different cellular context in which they are tested, this result should be seen as an indi-
cation at best. Further studies will need to address the nature of the BMP ligand/receptors and how
the deregulated BMP signalling affects endothelial cell migration and adherens junctions in the con-
text of YAP/TAZ deficiency.
Together, our results identify a role for YAP/TAZ in promoting endothelial cellular rearrange-
ments through the regulation of junctional turnover and collectiveness of cell migration. Conceptu-
ally, linking stretch-induced proliferation (to balance cell numbers) with modulation of junctional
turnover (to facilitate cell rearrangements) seems ideally suited to achieve the required balance of
cell distribution for functional vascular patterning.
Materials and methods
Key resources table
Reagent type (species)
or resource Designation Source or reference Identifiers Additional information
strain, strain background
(Mus musculus, C57BL/6J)
WT The Jackson laboratories
genetic reagent (Mus musculus) Yap iEC-KO, Yapfl/fl
Pdgfb-iCreERT2
PMID: 27215660,
PMID: 18257043
genetic reagent (Mus musculus) Taz iEC-KO, Tazfl/fl
Pdgfb-iCreERT2
PMID: 27215660,
PMID: 18257043
genetic reagent (Mus musculus) YapTaz iEC-KO, Yapfl/fl
Tazfl/fl Pdgfb-iCreERT2
PMID: 27215660,
PMID: 18257043
genetic reagent (Mus musculus) Taz iEC-GOF, TAZ S89A
EGFP Pdgfb-iCreERT2
This paper Cloning information in
Material and methods
and Figure 7—figure supplement 1
cell line (human) HUVEC PromoCell and Lonza
transfected construct (human) VE-Cadherin EGFP PMID: 24658686
transfected construct (human) VE-Cadherin mEos3.2 This paper Cloning information in
Material and methods
transfected construct (human) pCMV-flag S127A YAP Addgene, plasmid 27370
transfected construct (human) 3xFLAG-pCMV5-TOPO
TAZ(S89A)
Addgene, plasmid 24815
transfected construct (human) TEF-1 Luciferase
reporter (GTIIC)
PMID: 15628970
transfected construct (murine) RBPj Luciferase reporter PMID: 7566092
transfected construct (murine) BRE Luciferase reporter PMID: 11729207
Continued on next page
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Continued
Reagent type (species)
or resource Designation Source or reference Identifiers Additional information
transfected construct (human) FOPflash Luciferase
reporter
PMID: 9065401
transfected construct (Renilla) Renilla Luciferase
control reporter
Promega, E2241
antibody Yap (rabbit polyclonal) ThermoFisher Scientific,
PA1-461894
Dilution 1:100
antibody Taz (rabbit polyclonal) Sigma, HPA007415 Dilution 1:100
antibody Erg (goat polyclonal) Santa Cruz Biotechnology,
sc-18136
Dilution 1:100
antibody Erg (rabbit monoclonal) Abcam, Ab92513 Dilution 1:1000
antibody VE-Cadherin
(rat monoclonal)
BD Biosciences, 555289 Dilution 1:100
antibody VE-Cadherin
(goat polyclonal)
Santa Cruz Biotechnology,
sc-6458
Dilution 1:100
antibody VE-Cadherin 55–7 H1 -
Alexa-Fluor 647 Conjugate
BD Biosciences, 561567 Dilution 1:200
antibody TER-119 (rat monoclonal) R and D Systems, MAB1125 Dilution 1:100
antibody PECAM-1 (goat polyclonal) R and D Systems, AF3628 Dilution 1:200
antibody Cleaved caspase 3
(rabbit polyclonal)
R and D Systems, AF835 Dilution 1:200
antibody Dll4 (goat polyclonal) R and D Systems, AF1389 Dilution 1:100
antibody pSMAD1/5/8
(rabbit monoclonal)
Cell Signalling, 13820S Dilution 1:1000
antibody Phalloidin-
Alexa-Fluor 488
ThermoFisher
Scientific, A12379
Dilution 1:100
antibody Ib4-Alexa-Fluor 647
Conjugate
ThermoFisher
Scientific, I32450
Dilution 1:1000
antibody Ib4-Alexa-Fluor 488
Conjugate
ThermoFisher
Scientific, I21411
Dilution 1:1000
antibody Ib4-Alexa-Fluor 568
Conjugate
ThermoFisher
Scientific, I21412
Dilution 1:1000
antibody YAP 63.7
(mouse monoclonal)
Santa Cruz Biotechnology,
sc-101199
Dilution 1:1000
antibody GAPDH
(mouse monoclonal)
Millipore, MAB374 Dilution 1:4000
sequence-based reagent SMART pool: siGENOME
siRNA YAP
Dharmacon, M-012200-00-0005
sequence-based reagent SMART pool: siGENOME
siRNA TAZ
Dharmacon, M-016083-00-0005
sequence-based reagent SMART pool: siGENOME
siRNA VE-Cadherin
Dharmacon, M-003641-01-0005
sequence-based reagent SMART pool: siGENOME
siRNA Non targeting 1
Dharmacon, D001206-13-05
sequence-based reagent Taqman probes
for RT-qPCR
Taqman Supplementary file 3
commercial assay or kit Permeability assay -
Transwell membranes
Costar, 3460
commercial assay or kit Scratch wound assay -
Culture-Insert 2
Well in m-Dish 35 mm
Ibidi, 81176
commercial assay or kit Click-iT EdU Alexa
Fluor 647 Imaging Kit
ThermoFisher Scientific,
C10340
Continued on next page
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Continued
Reagent type (species)
or resource Designation Source or reference Identifiers Additional information
commercial assay or kit Propidium Iodide (PI)/
RNase Staining Solution
Cell Signalling, 4087
commercial assay or kit Rneasy Mini Kit Quiagen, 74104
commercial assay or kit M-MLV reverse transcriptase ThermoFisher Scientific,
28025013
commercial assay or kit RevertAid First Strand
cDNA Synthesis Kit
ThermoFisher Scientific,
K1621
commercial assay or kit Agilent RNA 6000 Nano Kit Agilent, 5067–1511
commercial assay or kit GeneChip Human
Gene 2.0 ST Array
ThermoFisher Scientific,
902113
chemical compound, drug 250 kDa FITC Dextran Sigma, FD250
chemical compound, drug Lipofectamine 2000 ThermoFisher Scientific,
11668019
chemical compound, drug Dharmafect 1
transfection reagent
Dharmacon, T-2001
chemical compound, drug Polybrene Santa Cruz, sc-134220
chemical compound, drug Hydroxytamoxifen Sigma, 7904
chemical compound, drug DBZ Cayman chemicals 14627
chemical compound, drug Recombinant-hGremlin R and D Systems, 5190-GR
chemical compound, drug Recombinant-hEndoglin R and D Systems, 1097-EN
chemical compound, drug LDN-193189 Cayman chemicals, 19396
chemical compound, drug K02288 Cayman chemicals, 16678
chemical compound, drug Recombinant hAlk1fc R and D Systems,
370-AL-100
chemical compound, drug VEGF-165 (murine) Prepotech, 450–32
software, algorithm FIJI FIJI
software, algorithm Cytoplasm to nucleus
translocation assay
Cell Profiler, adapted
from PMID: 17076895
software, algorithm Mouse retina
regularity script
This paper Source code 1
software, algorithm VE-Cadherin turnover
analysis script
This paper Source code 2
software, algorithm Patching script This paper Source code 3
software, algorithm Cell coordination
analysis script
This paper Source code 4
software, algorithm Dll4 gradient
analysis script
This paper Source code 5
Mice and treatments
For loss of function experiments the following mouse strains were used: Yap fl/fl and Taz fl/fl
(Gruber et al., 2016), Pdgfb-iCreERT2 (Claxton et al., 2008). A detailed description of the knock-in
mice overexpressing the TAZ gain-of-function allele will be provided elsewhere. Briefly, 3xFLAG-
TAZS89A-IRES-nEGFP with a preceding floxed STOP cassette was knocked into the Rosa26 locus.
Cre-mediated removal of the STOP sequence leads to CAG promoter-driven expression of 3xFLAG-
tagged TAZS89A as well as of nuclear-localized enhanced green fluorescence protein (nEGFP). The
allele was kept heterozygous in the experimental studies and was developed together with
genOway.
Mice were maintained at the London Research Institute and at the Max Delbruck Center for
Molecular Medicine (loss of function mice) and at the Max Planck Institute for Heart and Lung
Research (gain of function mice) under standard husbandry conditions. To induce Cre-mediated
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recombination 4-hydroxytamoxifen (Sigma, 7904) was injected intraperitoneally (IP) (20 mL/g of 1
mg/mL solution) at postnatal day 1 and day 3 and eyes were collected at P6. In all loss and gain of
function experiments control animals were littermate animals without Cre expression. Male and
female mice were used for the analysis.
For endothelial cell proliferation assessment in the retina, mouse pups were injected IP 2 hours
before culling with 20 uL/g of EdU solution (0.5 mg/mL; Thermo Fischer Scientific, C10340).
Cell culture
HUVECs from pooled donors (PromoCell) were cultured in EGM2-Bulletkit without antibiotics (Lonza)
and used until passage 6. For YAP and TAZ gain of function experiments HUVECs were obtained
from Lonza, cultured in endothelial basal medium (Lonza) supplemented with hydrocortisone (1 mg
ml 1), bovine brain extract (12 mg ml 1), gentamicin (50 mg ml 1), amphotericin B (50 ng ml 1), epi-
dermal growth factor (10 ng ml 1) and 10% fetal bovine serum (Life Technologies) and used until
passage 4. The manufacturers authenticated the identity of HUVECs by flow cytometry for cell-type
specific markers (vWF, CD31, CD105) and by functional analysis (cells positive for acetylated low
density lipoprotein uptake). All cells were tested negative for mycoplasma.
For knockdown experiments, HUVECs were transfected with SMARTpool: siGENOME siRNAs
purchased from Dharmacon (Yap #M-012200-00-0005, Taz #M-016083-00-0005, VE-Cadherin #M-
003641-01-0005 and non-targeting siRNA Pool 1 #D001206-13-05). Briefly, subconfluent (70–80%)
HUVECs were transfected with 25 nM siRNA using Dharmafect 1 transfection reagent following the
protocol from the manufacturer; transfection media was removed after 24 hr and experiments were
routinely performed on the third day after transfection.
To activate YAP and TAZ signalling in ECs, FLAG-YAPS127A- or 3x-FLAG-TAZS89A-encoding
adenoviruses were generated in the adenoviral type five backbone lacking the E1/E3 genes (Vector
Biolabs). GFP-encoding adenoviruses were used as a control. Infections were carried out by incubat-
ing sub-confluent HUVECs (70–80%) with starvation media (EBM containing 0.1% BSA) for 4 hr fol-
lowed by the addition of adenoviral particles and polybrene (Santa Cruz). After 4 hr, HUVECs were
washed with Hanks Buffer for at least five times and then cultured in complete EBM media with 10%
FCS and supplements overnight. All experiments were performed 24 hr post transduction.
Immunofluorescence staining
To perform retina immunofluorescence, eyes were collected from postnatal day six mice and fixed in
4% PFA in PBS for 1 hr at 4C. Retinas were dissected in PBS and permeabilised/blocked for 1 hr at
room temperature in 1% BSA, 2% FBS, 0.5% Triton X100, 0.01% Na deoxycholate and 0,02% Na
Azide in PBS. Primary and secondary antibodies were incubated overnight at 4C and for 2 hr at
room temperature, respectively, both in 1:1 PBS: blocking buffer. Isolectin staining was performed
overnight at 4C in Pblec after retinas were equilibrated for 1 hr in Pblec at room temperature. Reti-
nas were post-stained fixed in 2% PFA in PBS for 10 min. To mount the samples Vectashield mount-
ing medium. (Vector Labs, H1000) or ProLong Gold (Thermo Fisher Scientific) was used. Imaging
was done by laser scanning confocal microscopy (Carl Zeiss LSM700, LSM780 and Leica TCS SP8).
Processing of samples was carried out in tissues from littermates under the same conditions.
For immunofluorescence in HUVECs, cells were grown in #1.5 coverslips coated with poly-lysine
and gelatin 0.2%. At the end of the experiment cells were fixed in 4% PFA for 10 min, permeabilised
in 0.3% Triton-X100 in blocking buffer for 5 min and blocked in 1% BSA 20 mM Glycine in PBS for 30
min. Primary and secondary antibodies were incubated for 2 and 1 hr, respectively, in blocking
buffer. Nuclei labeling was performed by incubating cells with DAPI for 5 min (Life technologies,
D1306).
A list of the primary antibodies used can be found in Supplementary file 2.
Image analysis
Analysis of radial expansion, capillary density, branching frequency, proliferating ECs, apoptosis and
sprouting numbers was done using Fiji (Schindelin et al., 2012). Radial expansion corresponds to
the mean distance from the optic nerve to the sprouting front (eight measurements in tilescans of
two whole retinas per animal). Capillary density corresponds to the vessel area (measured by thresh-
olding IB4 signal) divided by the field of view area (6–8 images of (425 mm)2 between artery and vein
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per animal). Branching frequency was measured by manually counting all branching points in a field
of view (4–5 images of (200 mm)2 between artery and vein per animal). The plexus regularity was
assessed through the standard deviation of the size and the circularity of the vascular loops in the
plexus (using same images as for analysis of capillary density). Vascular loops were segmented by
thresholding the IB4 signal to avoid artifacts we excluded loops with a size smaller than 86 um^2 for
the analysis. Endothelial proliferation was measured by manually counting the number of EdU posi-
tive endothelial nuclei (ERG positive) and dividing by the vessel area (measured by thresholding IB4
signal) (4 images of (425 mm)2 containing the sprouting front and localized on top of arteries per ani-
mal). Apoptosis was measured manually by counting the number of cleaved caspase 3 positive fig-
ures and dividing by the vessel area (measured by thresholding IB4 signal) (tilescan of one whole
retina per animal). The number of sprouts was measured manually (3 images of 425  850 mm of the
sprouting front per animal). To quantify DLL4 intensity the outline of the sprouting front and the
position of the arteries were manually defined using IB4 staining. Vessels were segmented by thresh-
olding the IB4 staining in Fiji. Then, DLL4 intensity inside the vasculature was normalised with the
average DLL4 intensity outside of the vasculature. Subsequently, for every pixel inside the vascula-
ture (excluding the arteries) the distance to the sprouting front was calculated. The normalised DLL4
values within each bin were averaged (15 mm bins from 0 to 500 mm). For each retina quarter a curve
was obtained, and the average and SEM of these curves was shown in the graph (one retina quarter
was used per animal). To quantify pSMAD1/5/8 status the number of pSMAD1/5/8 positive endothe-
lial nuclei was manually counted and dividing by the total number of endothelial nuclei (defined by
being ERG positive) (3 images of (225 mm)2 containing the sprouting front were used per animal).
To analyse YAP/TAZ subcellular localisation in HUVECs we adapted a previously existing cyto-
plasm-to-nucleus translocation assay pipeline from Cell Profiler (Carpenter et al., 2006). Briefly, YAP
or TAZ staining intensity was measured both inside the nucleus of the cell and in a 12 pixels wide
ring of cytoplasm grown radially from the nucleus. The nucleus localisation was determined using a
DAPI mask.
Cell junction morphology analysis was done in confluent monolayers of HUVECs stained for VE-
Cadherin. Five morphological categories were defined: straight, thick, thick to reticular, reticular and
fingers. We acquired 5 images of (160 mm)2 per condition per experiment, divided each image in (16
mm)2 patches, and randomly grouped these patches. The classification into categories was done
manually and blindly for the condition.
To analyse cell coordination we used confluent cells labelled for DAPI. The nuclei were automati-
cally segmented using a customized Python algorithm relying on the Scikit Image Library. By fitting
an ellipse to each nucleus we obtained its major and minor axis, and the angle of the major axis with
the x-axis of the image was assigned to the nucleus as its orientation. This way each nucleus in the
images was assigned a position given by its midpoint and an orientation. Next we analyzed the aver-
age alignment of the nuclei of two cells depending on their distance. As the nuclei don’t have a
directionality (i.e. they are nematics as opposed to vectors), the angles between two nuclei range
from 0 corresponding to the nuclei being parallel, to p/2 corresponding to them spanning a right
angle. For any two cells in each image we calculated the angle and the Euclidean distance between
them, and then we binned the cells depending on their distance. We introduced a parameter called
’alignment’ which is one if all cells are perfectly aligned and 0 for a completely random distribution
of cell orientations.
Live imaging of VE-Cadherin-EGFP
24 hr after siRNA transfection, knockdown HUVECs were transduced with VE-cadherin-EGFP adeno-
virus as described before (Bentley et al., 2014). Briefly, cells were incubated with the virus for 24 hr
and then washed three times to remove viral particles. Cells were replated onto 2-well LabTek cham-
bered coverslips (Nunc) coated with 10 ug/mL Fibronectin (Sigma, F1141). Imaging was performed
48 hr post-transduction. Cells were imaged at 37˚C under 5% CO2 on LSM 780 (Zeiss) using a Plan-
Apochromat 63x/1.4 oil objective. Images were acquired at a 260 s time frame.
VEGF treatment and YAP/TAZ staining
Confluent HUVECs were maintained in VEGF free media for 24 hr. VEGF treatment was then per-
formed for 30 min, 1 hr and 3 hr with 0 or 40 ng/mL of VEGF-165 (PrepoTech, 450–32).
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Immunofluorescence staining and analysis of YAP and TAZ subcellular localisation was performed as
above described.
VEGF treatment and proliferation assessment
Knockdown HUVECs were maintained in VEGF free media for 24 hr. VEGF treatment was then per-
formed for 24 hr with 0 ng/mL, 40 ng/mL, 200 ng/mL or 1000 ng/mL of VEGF-165. Cells were pel-
leted, ressuspended in 90% cold Methanol and stored at  20C˚ before further processing. Cells
were then ressuspended in Propidium Iodide/RNase staining solution (Cell signaling, 4087) for 30
min before cell cycle analysis by flow cytometry (LSRII, BD). Data was analysed using BD FACSDiva
software.
Mechanical stretch application and proliferation assessment
HUVECs were plated on collagen I - 0.2% gelatine-coated Bioflex plates (BF-3001C, Flexcell Interna-
tional Corporation). Gene knockdown was preformed as previously described. Cells were incubated
in transfection media for 24 hr, and allowed to recover in fresh complete media for 4 hr. Afterwards
cells were incubated for 24 hr in serum starvation media (0,1%BSA in EBM2 pure media) to form a
confluent, quiescent monolayer. Cyclic stretch (0.25 Hz, 15% elongation) was then applied for 24 hr
using a Flexcell FX-5000 Tension System. Control cells were placed in the same incubator but not on
the Flexcell device (static conditions). EdU pulsing was performed after 20 hr of the 24 hr stretch
period. At the end of the experiment cells were fixed in 4% PFA and EdU staining was performed
according to the manufacturer’s protocol (Click-It EdU C10340 Life Technologies). Nuclei were
labelled with DAPI. Three regions of interested were acquired per sample in a Carl Zeiss LSM700
scanning confocal microscopes (Zeiss, Germany). Quantification of proliferation was done using a
CellProfiler pipeline. Percentage of S phase cells was determined as percentage of EdU positive
nuclei over the total number of nuclei.
Permeability assay
24 hr after siRNA transfection cells were re-plated into fibronectin coated Transwell membranes
(Costar 3460) at confluence and incubated for two more days to stabilize cell junctions. On the third
day after transfection 0.5 mg/mL of 250 kDa FITC Dextran in cell media (Sigma FD250) was added
to the top well. Fluorescence on the bottom well was measured after 6 hr in a Gemini XPS fluores-
cent plate reader.
Pulse chase VE-Cadherin experiment for quantification of low,
intermediate and high turnover junctions
Cells were labelled live with a non-blocking monoclonal antibody directed against extracellular VE-
Cadherin and directly coupled with Alexa-Fluor647 (BD Pharmingen, #561567, 1:200) for 30 min.
Cells were then washed 2x with PBS and incubated with complete media for additional 2 hr. Cells
were fixed with 4% PFA and stained for VE-Cadherin (Santa Cruz Biotechnology, #6458, 1:200) with
a secondary antibody coupled with Alexa-Fluor-488. 5 (160mm)2 images per condition per experi-
ment were acquired in a Carl Zeiss LSM700 confocal laser scanning microscope using the same
acquisition settings. Max projection of z stack and merging of channels was done in Fiji. Images
were divided in (16 mm)2 patches and the patches were randomly grouped. Patches were classified
into a morphological category and into low, intermediate or high turnover categories, manually and
blindly for the condition.
VE-cadherin mEos3.2 cloning
mEos3.2 cDNA (Zhang et al., 2012) was cloned downstream of full-length human VE-cadherin with
a short linker (ARDPPV) and inserted into pAc-GFP-N1 backbone (Clontech) using NEBbuilder HiFi
Assembly mix (NEB).
Fluorescent loss after photoconversion experiments
HUVECs double-transfected with YAP/TAZ or scrambled siRNAs and pN1-CMV-VE-cadherin-
mEos3.2 were cultured to confluency in 2-well LabTek chambered coverslips (Nunc) coated with 10
ug/mL Fibronectin (Sigma, F1141) in EGM (Promocell) supplemented with EGM2 bulletkit (Lonza).
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Cells were imaged at 37˚C under 5% CO2 on LSM 780 (Zeiss) equipped with Definite Focus stabi-
lizer. Imaging was performed using the 488 nm (green mEos3.2 component) and the 561 nm (red
component) lasers using Plan-Apochromat 63x/1.4 oil objective, 0.26  0.26 mm pixel size and 5.09
ms pixel dwell time, 16-bit image depth. A circular region of interest (ROI) of 21 mm2 area was
selected on straight junctions and photoconverted using the 405 nm laser. Mean fluorescence inten-
sity in the ROI was monitored in the red channel for 15 min with 10 s resolution, while the movement
of the junction was followed in the green channel.
Background signal in each frame was estimated by measuring mean intensity in non-photocon-
verted region and subtracted from the fluorescence-loss curves. The curves were further corrected
for bleaching, using parameters estimated from fixed cells. The curves were normalized between the
mean intensity in the frames before photoconversion and fluorescence intensity measured immedi-
ately after photoconversion. Normalized curves were smoothed using the moving average method;
the half-time of redistribution and immobile fraction of VE-cadherin were estimated directly from the
plots. Only junctions which did not substantially move or remodel during the observation time were
considered for analysis. Analysis was performed using Fiji and Matlab (Mathworks).
Scratch wound assay
24 hr after siRNA transfection cells were re-plated into a scratch wound assay device (IBIDI). On the
following day a cell free gap of 500 mm was created by removing the insert of the device. Images
were taken immediately after removing the insert (0 hr) and after 16 hr. The cell free area was mea-
sured in Fiji and used to calculate the percentage of wound closure at 16 hr.
RNA extraction and quantitative real time-polymerase chain reaction
RNA was extracted using the RNeasy Mini Kit (Qiagen) according to the manufacturer’s instructions.
For HUVECs transfected with adenoviruses carrying YAP and TAZ gain of function mutations, 2 mg of
total RNA were reverse transcribed to cDNA using M-MLV reverse transcriptase (ThermoFisher Sci-
entific). For HUVECs transfected with siRNAs 90 ng of RNA were reverse transcribed using RevertAid
First Strand cDNA Synthesis Kit (ThermoFisher Scientific). qRT-PCR was performed using TaqMan
reagents and probes (Applied Biosystems) (listed in Supplementary file 3). qRT-PCR reactions were
run on a StepOnePlus real-time PCR instrument (ThermoFisher Scientific) or Quant Studio 6 Flex
(Applied Biosystems) and expression levels were normalised to human ACTB or human HPRT1 using
the 2deltaCT method.
Western blot
Protein was extracted from HUVECs using M-PER protein extraction reagent with Halt Protease and
Phosphatase inhibitors (Pierce). Proteins concentration was assessed using a BCA protein assay kit
(Pierce). Proteins were separated by SDS–PAGE and blotted onto nitrocellulose membranes (Bio-
Rad). Membranes were probed with specific primary antibodies and then with peroxidase-conju-
gated secondary antibodies. The following antibodies were used: YAP 63.7 (Santa Cruz Biotechnol-
ogy, sc-101199, 1:1000), GAPDH (Millipore, MAB374, 1:4000). The bands were visualized by
chemiluminescence using an ECL detection kit (GE Heathcare) and a My ECL Imager (Thermo
Scientific).
Dual luciferase reporter assay
Renilla-luciferase reporter assays for TEF-1 (Mahoney et al., 2005), RBPj (Jarriault et al., 1995),
BRE (Korchynskyi and ten Dijke, 2002; Fritzmann et al., 2009) and FOPflash (Korinek et al.,
1997)-Luciferase promoter activity were performed as follows: 48 hr after gene knockdown by siRNA
HUVECs were cotransfected with 600 ng of Luciferase reporter gene construct and 300 ng of pRL-
TK (Promega) using Lipofectamine2000 and incubated for 4 hr. Cell extracts were prepared 72 hr
post siRNA transfection and 24 hr post Luciferase reporter transfection, and luciferase activity was
measured using a dual luciferase system as described (Hampf and Gossen, 2006). Experiments
were carried out in duplicates and results were normalized to the correspondent FOPflash/Renilla
measurement.
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Microarray and gene set enrichment analysis
Microarray studies were performed as described(Murtaugh et al., 2003). In brief, total RNA was
extracted from HUVECs using the RNeasy kit (Qiagen) and RNA quality assessed with the 6000 nano
kit and an Agilent Bioanalyser. RNA was labelled according to the Affymetrix Whole Transcript Sense
Target Labeling protocol. Affymetrix GeneChip Human Gene 2.0 ST arrays were hybridized and
scanned using Affymetrix protocols. Data were analysed using the Affymetrix expression console
using the RMA algorithm; statistical analysis was done using DNAStar Arraystar 11. Heat maps of
gene signatures were plotted using RStudio, Inc.
Notch and BMP inhibition experiments
A list of the reagents used, together with duration of treatment, can be found in Supplementary file
1.
Statistical analysis
Statistical analyses were performed using GraphPad Prism software and p value was determined
using unpaired Student t-test between the control and the knockout/knockdown/ gain of function
condition. Statistical significance was considered for p<0.05. Values shown are mean and standard
deviation was used as the dispersion measure. Biological replicates refer to individual mice for in
vivo experiments and different wells for in vitro cell culture experiments; independent experiments
refer to experiments done in different days; technical replicates refer to repeated measurements
taken from the same sample, both for in vivo and in vitro. Exclusion of outliers was done using
‘Robust regression and Outlier removal’ from GraphPad Prism software, with a coefficient Q of 1%.
A statistical method of sample size calculation was not used during study design. For in vivo experi-
ments, we used an average of 6 animals per experiment, from different litters, with a minimum of 3
(detailed number of animals used in figure legends and source data). For in vitro experiments, we
did a minimum of 3 independent experiments (detailed number of experiments in figure legends
and source data). When technically possible the investigators were blind to the genotype of the ani-
mal or cell culture condition during sample processing and data analysis.
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